Shanghai LePure Biotechnology Co., Ltd.
PrivateLast Round
Series C
Jan 17, 2023
Est. Valuation
$261.54M
Total Funding Raised
$125.55M
Company Overview
Shanghai LePure Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series C round in January 2023.
Shanghai LePure Biotechnology Co., Ltd. is a biotechnology company that provides single-use bioprocessing solutions, including consumables, equipment, and validation services, for the biopharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Pharma Supply Chain, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai LePure Biotechnology Co., Ltd. Comparables
Compare Shanghai LePure Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duoning Biotechnology | 88% | |
| BioLink | 84% | |
| Cobetter Filtration | 83% |
For institutional investors. Book with your work email.
Shanghai LePure Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 17, 2023 | ||||
| Strategic | Nov 25, 2022 | ||||
| Strategic | Jul 18, 2022 | ||||
| VC Round | Feb 18, 2022 | ||||
| Series B Extension | Dec 18, 2021 | ||||
Series B | Apr 2, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Shanghai LePure Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | VC Round, Series C, Strategic |
| Hillhouse Investment | Series B Extension |
| Goldman Sachs (Asia) LLC | Strategic |
| Huimei Capital | Strategic, Series B Extension, Series C |
| Goldman Sachs Asset Management Private Equity | Series C |
| Legend Capital | Series B Extension, Series B |
| CICC Capital | Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 17, 2023
$126M round led by Goldman Sachs, Novo Holdings, and General Atlantic.
- Nov 25, 2022
Raised a strategic round with participation from Huimei Capital.
For institutional investors. Book with your work email.
Shanghai LePure Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai LePure Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai LePure Biotechnology Co., Ltd. a public or private company?
Shanghai LePure Biotechnology Co., Ltd. is a private company.
What is the current stock price of Shanghai LePure Biotechnology Co., Ltd.?
Shanghai LePure Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai LePure Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai LePure Biotechnology Co., Ltd. worth (valuation)?
Shanghai LePure Biotechnology Co., Ltd.'s valuation is estimated at $261.5M based on funding round data.
Can I buy Shanghai LePure Biotechnology Co., Ltd. stock?
Shanghai LePure Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai LePure Biotechnology Co., Ltd.'s last funding round?
Shanghai LePure Biotechnology Co., Ltd.'s most recent funding round was Series C on January 17, 2023.
Who are the main investors in Shanghai LePure Biotechnology Co., Ltd.?
Key investors in Shanghai LePure Biotechnology Co., Ltd. include Goldman Sachs Asset Management Private Equity, Legend Capital, Novo Holdings, General Atlantic.
Will Shanghai LePure Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai LePure Biotechnology Co., Ltd..
How can I track Shanghai LePure Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai LePure Biotechnology Co., Ltd.'s shares on secondary markets.